Literature DB >> 14701837

Inhibition of proteasomal function by curcumin induces apoptosis through mitochondrial pathway.

Nihar Ranjan Jana1, Priyanka Dikshit, Anand Goswami, Nobuyuki Nukina.   

Abstract

Curcumin is a natural polyphenolic compound having an antiproliferative property, which recent evidence suggests is due to its ability to induce apoptosis. However, the molecular mechanisms through which curcumin induces apoptosis are not fully understood. Here, we report that the curcumin-induced apoptosis is mediated through the impairment of the ubiquitin-proteasome system. Exposure of curcumin to the mouse neuro 2a cells causes a dose-dependent decrease in proteasome activity and an increase in ubiquitinated proteins. Curcumin exposure also decreases the turnover of the destabilized enhanced green fluorescence protein, a model substrate for proteasome and cellular p53 protein. Like other proteasome inhibitors, curcumin targets proliferative cells more efficiently than differentiated cells and induces apoptosis via mitochondrial pathways. Addition of curcumin to neuro 2a cells induces a rapid decrease in mitochondrial membrane potential and the release of cytochrome c into cytosol, followed by activation of caspase-9 and caspase-3.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14701837     DOI: 10.1074/jbc.M310369200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

Review 1.  Targeting tumor ubiquitin-proteasome pathway with polyphenols for chemosensitization.

Authors:  Min Shen; Tak Hang Chan; Q Ping Dou
Journal:  Anticancer Agents Med Chem       Date:  2012-10-01       Impact factor: 2.505

Review 2.  Is insulin signaling molecules misguided in diabetes for ubiquitin-proteasome mediated degradation?

Authors:  Muthuswamy Balasubramanyam; Rangasamy Sampathkumar; Viswanathan Mohan
Journal:  Mol Cell Biochem       Date:  2005-07       Impact factor: 3.396

3.  Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication.

Authors:  Xiaoning Si; Yahong Wang; Jerry Wong; Jingchun Zhang; Bruce M McManus; Honglin Luo
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

4.  Proteasome inhibitor does not enhance MPTP neurotoxicity in mice.

Authors:  Naoto Kadoguchi; Masahiro Umeda; Hiroyuki Kato; Tsutomu Araki
Journal:  Cell Mol Neurobiol       Date:  2008-03-14       Impact factor: 5.046

5.  Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo.

Authors:  Vesna Milacic; Sanjeev Banerjee; Kristin R Landis-Piwowar; Fazlul H Sarkar; Adhip P N Majumdar; Q Ping Dou
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

6.  Disuccinyl betulin triggers metacaspase-dependent endonuclease G-mediated cell death in unicellular protozoan parasite Leishmania donovani.

Authors:  Sayan Chowdhury; Tulika Mukherjee; Somenath Roy Chowdhury; Souvik Sengupta; Sibabrata Mukhopadhyay; Parasuraman Jaisankar; Hemanta K Majumder
Journal:  Antimicrob Agents Chemother       Date:  2014-01-27       Impact factor: 5.191

7.  CNS delivery and pharmacokinetic evaluations of DALDA analgesic peptide analog administered in Nano-sized oil-in-water emulsion formulation.

Authors:  Lipa Shah; Florence Gattacceca; Mansoor M Amiji
Journal:  Pharm Res       Date:  2013-12-03       Impact factor: 4.200

Review 8.  Medicinal plants and cancer chemoprevention.

Authors:  Avni G Desai; Ghulam N Qazi; Ramesh K Ganju; Mahmoud El-Tamer; Jaswant Singh; Ajit K Saxena; Yashbir S Bedi; Subhash C Taneja; Hari K Bhat
Journal:  Curr Drug Metab       Date:  2008-09       Impact factor: 3.731

9.  Curcumin induces apoptosis-independent death in oesophageal cancer cells.

Authors:  G O'Sullivan-Coyne; G C O'Sullivan; T R O'Donovan; K Piwocka; S L McKenna
Journal:  Br J Cancer       Date:  2009-10-06       Impact factor: 7.640

10.  Monoketone analogs of curcumin, a new class of Fanconi anemia pathway inhibitors.

Authors:  Igor Landais; Sanne Hiddingh; Matthew McCarroll; Chao Yang; Aiming Sun; Mitchell S Turker; James P Snyder; Maureen E Hoatlin
Journal:  Mol Cancer       Date:  2009-12-31       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.